Jeffrey Tyner
Impact in
- Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 157
- Acute Myeloid Leukemia Research 112
- Chronic Myeloid Leukemia Treatments 69
- Genetics 86
- Chronic Lymphocytic Leukemia Research 50
- Myeloproliferative Neoplasms: Diagnosis and Treatment 36
- Co-authors
- Brian J. Druker (111 shared papers)Marc Loriaux (55 shared papers)Julia E. Maxson (20 shared papers)Michael W. Deininger (24 shared papers)Christopher A. Eide (43 shared papers)Anupriya Agarwal (34 shared papers)McWeeney Shannon (44 shared papers)Bill H. Chang (30 shared papers)
- Journals
- Blood (78 papers)Leukemia (18 papers)Cancer Cell (10 papers)Cancer Research (10 papers)Clinical Cancer Research (8 papers)
- Partner nations
- United StatesIndiaSingapore
In The Last Decade
Jeffrey Tyner
256 papers receiving 17.3k citations
Jeffrey Tyner's Hit Papers
Peers
Comparison fields: 5 of 140
- Hematology 7.5k
- Genetics 4.5k
- Cancer Research 1.9k
- Immunology 2.5k
- Oncology 2.7k
Countries citing papers authored by Jeffrey Tyner
This map shows the geographic impact of Jeffrey Tyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Tyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Tyner more than expected).
Fields of papers citing papers by Jeffrey Tyner
This network shows the impact of papers produced by Jeffrey Tyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Tyner. The network helps show where Jeffrey Tyner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Tyner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 265 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms Hit paper breakdown → | 2022 | 2560 |
| 2 | AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance Hit paper breakdown → | 2009 | 1045 |
| 3 | Functional genomic landscape of acute myeloid leukaemia Hit paper breakdown → | 2018 | 997 |
| 4 | CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability Hit paper breakdown → | 2010 | 658 |
| 5 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2019 | 549 |
| 6 | Proteogenomic and metabolomic characterization of human glioblastoma Hit paper breakdown → | 2021 | 456 |
| 7 | 2008 | 455 | |
| 8 | OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML Hit paper breakdown → | 2013 | 451 |
| 9 | Proteogenomic Characterization of Endometrial Carcinoma Hit paper breakdown → | 2020 | 354 |
| 10 | 2019 | 293 | |
| 11 | 2006 | 278 | |
| 12 | 2005 | 256 | |
| 13 | 2021 | 251 | |
| 14 | Integrative analysis of drug response and clinical outcome in acute myeloid leukemia Hit paper breakdown → | 2022 | 251 |
| 15 | 2006 | 230 | |
| 16 | 2017 | 213 | |
| 17 | 2013 | 208 | |
| 18 | 2010 | 205 | |
| 19 | 2017 | 196 | |
| 20 | 2019 | 184 |
About Jeffrey Tyner
Jeffrey Tyner is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Immunology, having authored 265 papers that have together received 17.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (112 papers), Chronic Myeloid Leukemia Treatments (69 papers), Chronic Lymphocytic Leukemia Research (50 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Acute Lymphoblastic Leukemia research (32 papers), Protein Degradation and Inhibitors (30 papers), Cancer Genomics and Diagnostics (16 papers) and Cytokine Signaling Pathways and Interactions (15 papers). The work is most often cited by research in Hematology (7.5k citations), Genetics (4.5k citations), Cancer Research (1.9k citations), Immunology (2.5k citations) and Oncology (2.7k citations). Jeffrey Tyner has collaborated with scholars based in United States, India and Singapore. Frequent co-authors include Brian J. Druker, Marc Loriaux, Julia E. Maxson, Michael W. Deininger, Christopher A. Eide, Anupriya Agarwal, McWeeney Shannon, Bill H. Chang, Elie Traer and Jason Gotlib. Their work appears in journals such as Blood, Leukemia, Cancer Cell, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.